about
Human papillomavirus vaccine: a paradigm shift for pediatricians.Acute complications of Epstein-Barr virus infectious mononucleosis.Performance of two commercial glycoprotein G-based enzyme immunoassays for detecting antibodies to herpes simplex viruses 1 and 2 in children and young adolescentsTransfection of a rearranged viral DNA fragment, WZhet, stably converts latent Epstein-Barr viral infection to productive infection in lymphoid cells.Integrating quality improvement and residency education: insights from the AIAMC National Initiative about the roles of the designated institutional official and program director.Human herpesvirus 8 infection.Natural history of primary Epstein-Barr virus infection in children of mothers infected with human immunodeficiency virus type 1.Systemic and mucosal differences in HIV burden, immune, and therapeutic responsesEvaluation of coxsackievirus infection in children with human immunodeficiency virus type 1-associated cardiomyopathyThe changing picture of hepatitis A in the United States.The epidemiology of viral hepatitis in children in South Texas: increased prevalence of hepatitis A along the Texas-Mexico border.Seroprevalence of Kaposi's sarcoma-associated herpesvirus infection among blood donors from Texas.Molecular polymorphism of Kaposi's sarcoma-associated herpesvirus (Human herpesvirus 8) latent nuclear antigen: evidence for a large repertoire of viral genotypes and dual infection with different viral genotypes.The role of intravenous immunoglobulin for the prevention and treatment of neonatal sepsis.Risk factors for pediatric human immunodeficiency virus-related malignancy.Detection of EBV DNA in the cord blood donor for a patient developing Epstein-Barr virus-associated lymphoproliferative disorder following mismatched unrelated umbilical cord blood transplantation.Epidemiology of herpesvirus papio infection in a large captive baboon colony: similarities to Epstein-Barr virus infection in humans.Characterization of natural Epstein-Barr virus infection and replication in smooth muscle cells from a leiomyosarcoma.Association of Epstein-Barr virus with leiomyosarcomas in young people with AIDS.Serologic crossreactions among primate immunoglobulins.High prevalence of human herpesvirus 8 (HHV-8) infection in south Texas childrenAbsence of herpesvirus DNA sequences in the 5T murine model of human multiple myelomaEvaluation and treatment of congenital syphilisAbsence of herpesvirus in AIDS-associated smooth-muscle tumorsMeningococcal vaccine: new recommendations for immunization of college freshmenSmokeless tobacco extracts modulate exogenous gene expression in early passage cultured human oral epithelial cells: an in vitro system to study chemical and viral enhancer/promoter interactionEvaluation of human herpesvirus type 8 infection in childhood langerhans cell histiocytosisImpact of pneumococcal and influenza vaccines on otitis mediaInternet resources for pediatric infectious diseasesNew recommendations for influenza vaccination for children and pregnant womenThe infectious disease profile of Texas prison inmatesThe immunization schedule confronts adolescenceHuman papillomavirus vaccine: now for boys too?Epstein-Barr virus
P50
Q33157143-591C63D4-3E65-4FC4-8F38-9CA2D370555AQ33332642-302D2F8E-2B18-4A69-9DDD-080B0D4A574FQ33944535-6A6D9378-C3DE-443A-A098-F3DA48B70867Q34601537-7810318C-EDBE-4456-87D2-24DED7470784Q35014641-F7473404-1936-4251-AF5A-0C18496CD0C3Q35051763-08AD883F-9A43-44AA-A974-A478A1E902ACQ35178721-04186371-F020-4C8D-BED4-D9C63E115EECQ35190200-2D63DEA9-3275-49E3-824D-2C74A99469A6Q35578679-C4C706D5-C2E5-4353-832A-841C27303A6BQ35646773-0662AAC0-107D-401C-B2C6-BBA2CB54C708Q39512059-A54BC002-22F4-424A-8973-393035051054Q40686461-CF5BF6F7-F24E-4EF4-95DB-ED54265AE144Q40923894-E0222CA1-C8E7-4042-A38C-0B678E3785DDQ41730070-71479C3E-B800-48FE-A929-029DA82C8F0BQ45723612-948488C4-C87C-4C12-AD04-340724901465Q45737302-E202EC73-9923-429F-AA69-A95FFE56BA9BQ45743175-3336E8E6-4A35-447F-A903-5A094DC0167CQ45751764-2D08A892-7E63-43D2-8530-36371021A7E3Q45781865-78D332CB-042E-4AD7-AF6C-26DDF9DC0B42Q52846001-66A366F0-408E-42C7-9AF0-04E22603E9E9Q56506794-F429B191-1C00-4436-A5CD-1780614D72BFQ56506965-46C7F8F2-C02B-4F0C-A435-3F52C34C4FCFQ68487152-F040A072-6656-405E-8FBD-26AC0C868997Q71890778-5BAC2519-7D70-4009-822C-617DEA00BABEQ73436184-29A81F7B-DCF0-41E5-B362-F13E6B54C13BQ73980946-1AA038A5-0830-43A0-84C6-CEA913E40D1BQ74055977-C1952681-BAB9-482E-B7AE-FC564B50032BQ75393714-5BFAB6CC-5F13-47B6-9449-DCBE997EA6A5Q77733814-CC416C96-78DF-46BE-9B10-C769088D3513Q78835742-B0B4EE64-FED8-4476-B89C-1D5C27555AA1Q79878532-80AF2EF8-5951-49B8-A735-EE121F7EDFBFQ81296579-6BBF6E49-17C6-4E6B-A12D-84211D4021D0Q82883859-77E1A24F-B9F0-40CD-876F-D1C6FF936306Q84874696-74E4C887-0E32-46D2-A6A4-C0225E454FA2
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-6549-860X
@en
name
Hal B Jenson
@ast
Hal B Jenson
@en
Hal B Jenson
@es
Hal B Jenson
@nl
type
label
Hal B Jenson
@ast
Hal B Jenson
@en
Hal B Jenson
@es
Hal B Jenson
@nl
prefLabel
Hal B Jenson
@ast
Hal B Jenson
@en
Hal B Jenson
@es
Hal B Jenson
@nl
P106
P1153
25943494100
P31
P496
0000-0002-6549-860X